Leader in T Cell immunology. TCR targeting PRAME (AML, MDS, MM) entered clinic March 2018. CTA submitted for TCR targeting MAGE-A1 (MM, liver, and lung cancer); several add'l undisclosed targets & indications in PC dev't. DC vax in ongoing Ph 1/2; final readout in 2019. Lucrative R&D collaboration w. bluebird bio (BLUE).
Lochhamer Str. 11
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Stock Market Data
Market Data copyright © 2017 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by